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doi:10.1016/j.ejvs.2010.12.005Abstract Background: Endoluminal repair of thoracic aortic pathology has become estab-
lished in clinical practice, but is associated with significant neurological complications. The
aim of this study was to identify factors that were predictive of stroke and paraplegia.
Methods: Prospective data was collected for a cohort of 293 consecutive patients having
thoracic aortic endovascular repair between August 1997 and September 2009. Patient and
procedural characteristics were related to the incidence of stroke and paraplegia using multi-
variate logistic regression analysis.
Results: The median age was 68 years (18e87), there were 191 men and 102 women. Mortality
was 5.1% for 195 elective and 13.4% for 98 urgent patients. Stroke affected 16 (5.5%) patients:
11 affected the anterior and 5 the posterior circulation. Coverage of the left subclavian artery
with no revascularisation was the only significant factor predictive of stroke (OR 5.34
(1.42e20.40) PZ 0.01). Paraplegia affected 16 patients (5.5%) but no independent risk factor
was identified: 12 were identified perioperatively and 4 were delayed by up to 6 months.
Conclusion: Covering the left subclavian artery without revascularisation increases the risk of
stroke following endoluminal repair of thoracic pathology. Paraplegia appears to be more
complex and no independent precipitating factor was identified.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Endovascular repair of the thoracic aorta has been adopted as
thefirst line therapyfor treatingmultipleaorticpathologies.1,2education questions on this pape
.ac.uk (R.E. Clough).
ty for Vascular Surgery. PublisheLarge series document mortality and morbidity rates that are
substantially lower than those of comparable open surgery.3,4
Endovascular devices and user expertise have improved over
recent years but the procedure is still associated withr, please go to www.vasculareducation.com and click on ‘CME’.
d by Elsevier Ltd. All rights reserved.
Table 1 Absolute indications for left subclavian artery
revascularisation.
Indication
1. Patent left internal mammary artery coronary
bypass graft
2. Diminutive, atretic or absent right vertebral artery
3. Left arm arterio-venous fistula for haemodialysis
4. Patent left axillo-femoral bypass graft
5. Dominant left vertebral arterya
a Indication evolved during the study.
Table 2 Patient demographics and procedure details.
Variable
Age (median (range)) 68 (18e87)
Gender (male:female) 191:102
Aortic pathology Aneurysm 159
Chronic Type B dissection 51
Acute Type B dissection 33
Infection 19
Transection 18
Coarctation aneurysm 7
Penetrating ulcer 5
Operative trauma 1
Infra-renal aorta Co-existing aneurysm 47
Previous open repair 30
Previous endovascular
repair
18
Operative status Elective 195
Urgent/Emergency 98
Anaesthetic type Loco-regional 221
General 72
Device type Gore TAG 141
Cook TX2 54
Gore Excluder 46
Medtronic Talent 18
Endomed Endofit 18
Medtronic AneuRx 6
Bolton Relay 6
Other 4
Ishimaru zone 3 172
2 87
1 32
0 2
304 R.E. Clough et al.significant neurological morbidity. Stroke and paraplegia rates
remain in the region of 2e9% and 0e10% respectively.5e11
Coverage of the left subclavian artery has been reported to
increase the incidence of stroke and spinal cord ischaemia but
there is nodefinitiveevidence to suggest that revascularisation
of the left subclavian artery (LSCA) should always be per-
formed.7,12,13 Identification of factors associated with stroke
and paraplegia may enhance our understanding of the aeti-
ology of these complications, improve procedural techniques
and allow individual patient risk stratification.
The aim of this study was to review the neurological
complications in our series and identify factors predictive
of perioperative stroke and paraplegia.
Methods
The cohort consisted of 293 consecutive patients with
thoracic aortic pathology who underwent endovascular
treatment between August 1997 and September 2009. A
prospectively maintained database, case notes and
imaging studies were retrospectively reviewed and patient
and procedural characteristics were collated on a stand-
ardised proforma. All procedures were performed in
a hybrid operating theatre with fluoroscopic and angio-
graphic equipment available. Vascular access was achieved
via femoral arteriotomy or iliac Dacron conduit. A catheter
was inserted in the contralateral groin so that continuous
angiography could be performed during device deploy-
ment. Pre-operative imaging consisted of computed
tomography angiography, duplex sonography and intra-
arterial digital subtraction angiography. The absolute
indications for left subclavian artery revascularisation are
shown in Table 1.The majority of procedures were per-
formed under loco-regional anaesthesia without routine
pre-operative placement of a cerebrospinal fluid (CSF)
drain. Prophylactic spinal drain insertion was considered if
the procedure was performed under general anaesthetic,
there was long segment coverage of the descending
thoracic aorta, occlusion of the left subclavian artery,
extensive disease or occlusion of the internal iliac arteries,
or previous infra-renal aortic repair. Once the CSF drain
was established the pressure was kept at 12 cm of water. If
the drain output was more than 20 mL per hour, then the
drain was clamped and released the following hour,
providing the patient remained without symptoms. If the
patient remained paraplegic then the pressure was
reduced to 10 cm of water. The systemic blood pressure
was elevated with inotropes to a mean arterial pressure of
90 mmHg.
Statistical analysis
SPSS Statistics 17.0 software was used for statistical analysis.
Quantitative variables were expressed as median and range.
The relationship between stroke and paraplegia was
compared with patient and procedural characteristics, and
corresponding odds ratios were calculated using univariate
and multivariate logistic regression analysis. Renal impair-
ment was defined as glomerular filtration rate (GFR)< 90mL/
min/1.73m2or a serumcreatinine> 120mmol/L.13,14AP value
of 0.05 was considered significant.Results
Patient characteristics
The pathology, demographics and procedural details are
shown in Table 2. The male: female ratio was 191:102 and
the median age was 68 years (18e87). Aneurysm was the
most common pathology. Aortic rupture, symptomatic
aneurysms, acute dissection, transection and infected
cases were classified as urgent and this group included 33%
of all cases (98/293). Seventy-five per cent of the cases
were treated under loco-regional anaesthesia (221/293)
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patients had just the LSCA covered (29.7%), with revascu-
larisation in 9.2% (8/87). The LSCA and left common carotid
artery (LCCA) were covered in 32 patients (10.9%); all had
a carotidecarotid bypass and the LSCA was revascularised
in 7 (21.9%). Ninety-five patients (32.4%) had either a co-
existing abdominal aortic aneurysm (AAA) or a previous
infra-renal aortic repair.
The overall in-hospital mortality was 7.8%: 5.1% in the
elective group and 13.4% in the urgent group. There were 23
deaths in the series and themost common cause of deathwas
stroke (Table 3). Three patients died from failure to secure
a proximal seal with continued perfusion of a ruptured
aneurysm sac and two died from the complications of
massive blood loss. Only one patient with paraplegia died.
Stroke
Sixteen patients had a stroke and their demographics are
shown in Table 4. The most common pathology was aneu-
rysm. Two patients had previously had a neurological event
and one patient had undergone carotid endarterectomy on
the affected side four weeks prior to thoracic aortic
intervention. Half of the patients required urgent treat-
ment. Ten patients were treated under loco-regional
anaesthesia and six under general anaesthesia. The LCCA
was partially covered by the stent graft in two patients. In
nine patients the left subclavian artery was covered and
was revascularised by left carotid to subclavian artery
bypass in one patient. This patient had a posterior circu-
lation stroke. Neurological symptoms consistent with
a stroke were present by the end of the procedure in ten
patients, whereas in six they were delayed up to post-
operative day twenty. Eleven of the strokes were related to
the anterior circulation and five to the posterior circula-
tion. In all patients the aetiology was infarction. In eight of
the patients with an anterior circulation stroke the primary
pathology was aneurysm, whereas this pathology affected
only one patient with a posterior circulation event. Three
patients had a good recovery and were discharged home. In
thirteen the neurological deficit was permanent and six
of these patients died and five required neuro-rehabilita-
tion. Multivariate logistic regression analysis showed
that coverage of the left subclavian artery withoutTable 3 Causes of death in the elective group, the urgent
group, and for the series as a whole.
Cause of death Elective Urgent Total number
affected
Stroke 1 5 6
Myocardial infarction 0 3 3
Bowel ischaemia 3 0 3
Proximal endoleak 3 0 3
Blood loss 0 2 2
Rupture infra-renal aorta 0 2 2
Pneumonia 1 1 2
Pulmonary embolus 1 0 1
Paraplegia 1 0 1
Total 10 13 23revascularisation was the only significant variable associ-
ated with stroke (OR 5.38 (1.42e20.40) PZ 0.01) (Table 5).
Paraplegia
Sixteen patients had paraplegia and their demographics are
shown in Table 6. The most common pathology was aneu-
rysm and seven patients required urgent treatment. Two
patients with acute dissection presented with paraplegia
and were treated with insertion of a spinal drain in the
anaesthetic room prior to endoluminal repair. Fifteen
patients were treated under loco-regional anaesthesia and
one under general anaesthesia. The left subclavian artery
was covered in seven and revascularised by a left carotid to
subclavian artery bypass in two. Eight patients had under-
gone a previous infra-renal aneurysm repair or had a co-
existing aneurysm. The median length of stent graft was
40 cm (10e55). One patient had an iliac conduit for access
and two patients required a femoro-femoral crossover graft
for injury to the iliac vessels. Paraplegia was present by the
end of the procedure in twelve patients. Intra-operative
hypotension was the precipitating cause in four patients
and four had extensive thoracic coverage from the left
common carotid artery to the coeliac axis. In four patients
the presentation of paraplegia was delayed by up to six
months. Two were related to insertion of an extension cuff
to seal a proximal or distal endoleak, and one was related
to hypotension following a myocardial infarction at three
weeks. All patients with paraplegia were treated with
a cerebrospinal fluid (CSF) drain at the time of diagnosis.
One patient developed a subdural haematoma as a compli-
cation of CSF drainage. One patient required internal iliac
artery angioplasty to maintain perfusion of the spinal cord
which permanently reversed the neurological symptoms.
Three patients required inotropes to maintain the mean
arterial pressure greater than 90 mmHg. Twelve patients
made a good recovery and eight went home. In four
patients the neurological deficit was permanent and one
patient died. Univariate logistic regression analysis
demonstrated a relationship between presence of a co-
existing infra-renal aneurysm or a previous infra-renal
repair and paraplegia (Table 7). Multivariate logistic
regression analysis did not demonstrate a causal relation-
ship with any patient or procedural characteristic (Table 5).Discussion
The aetiology of stroke and paraplegia following endovas-
cular repair of thoracic aortic pathology is multifactorial.
The aim of this paper was to try to identify factors
predictive of neurological complications. The only factor in
this series shown to be an independent predictor of stroke
was intentional coverage of the left subclavian artery
without revascularisation. A relationship between length of
stent graft and stroke was shown on univariate analysis and
this may reflect more proximal intervention within the
aortic arch. In this series eight of the sixteen patients with
paraplegia had a co-existing infra-renal aortic aneurysm or
a previous infra-renal repair and this relationship was
shown to be significant at univariate but not multivariate
analysis.
Table 4 Demographics of patients with stroke.
Patient Age
& Sex
Major co-
morbidities
Presentation Pathology Pre-operative
imaging
Anaesthetic
type
Device Vessels
covered
1 79 M Angina; CVA Urgent Aneurysm CT; angio gram LA TAG LSCA
2 57 F No Urgent Mycotic CT GA TAG LCCA (partial)
LSCA
3 44 M No Urgent Acute dissection CT Epidural TAG LCCA
LSCA; coeliac;
SMA; renals
(stent in
false lumen)
4 83 M AF Elective Aneurysm CT Spinal TAG LSCA
5 51 F No Elective Transection CT GA TAG LSCA
6 61 M CABG Elective Aneurysm CT Epidural Endofit No
7 65 M No Elective Aneurysm CT Epidural TAG LSCA
8 74 M No Urgent Aneurysm CT GA TX2 LSCA
9 61 M AF Elective Chronic dissection CT; duplex Epidural TAG LCCA
LSCA
10 64 F Renal
impairment
Urgent Aneurysm CT; angio gram Epidural TX2 No
11 53 M Renal
impairment
Urgent Acute dissection CT Epidural TX2 LCCA (partial)
LSCA
12 72 F CVA Elective Aneurysm CT; duplex LA TAG LSCA; coeliac
artery
13 74 F MI Urgent Aorto-bronchial
fistula
CT GA TAG No
14 70 M COPD Urgent Acute dissection CT GA TAG No
15 76 M Elective Aneurysm CT Epidural TAG No
16 76 F Elective Aneurysm CT Epidural TAG No
306 R.E. Clough et al.Previous studies have shown an inconsistent clinical
response to coverage of the left subclavian. A systematic
review and meta-analysis found that left subclavian artery
coverage, with or without revascularisation was associated
with an increased risk of stroke.12 It has been shown that
intentional coverage of the left subclavian artery during
thoracic endovascular repair increased the rate of vertebro-
basilar ischaemia, andpossibly anterior circulation strokeand
spinal cord ischaemiabut theevidencewas very lowquality.15
Others were unable to demonstrate an association between
stroke and coverage of the left subclavian artery and
concluded that stroke was not related to left subclavian
artery coverage and that there was no significant difference
in stroke rate between the revascularised and non-revascu-
larised groups.13,16 The European Collaborators on Stent
Graft Techniques for Aortic Aneurysm Repair (EUROSTAR)
registry also reported no significant increase in stroke with
left subclavian coverage.7
In stroke the ischaemic insult may be related to the
balance between the damage caused by emboli or haemo-
dynamic insufficiency and the ability of the collateral
circulation to maintain tissue perfusion. Coverage of the
left subclavian artery may reduce cerebral blood flow,
directly resulting in a posterior stroke or an anterior
circulation stroke by reducing the haemodynamic reserve
via the Circle of Willis. Patients with aneurysmal disease
may have more atheromatous material in the aortic arch
and therefore be more prone to embolisation to both theanterior and posterior cerebral circulation during guide-
wire, catheter and device manipulation.
The recent recommendation by the Society for Vascular
Surgery to revascularise the left subclavian artery in all
patients having planned coverage of its origin is supported
by our results. There are however some patients who may
not benefit such as patients with a small or absent left
vertebral artery and those with a dominant right vertebral
artery proven on both arterial duplex scan and cross
sectional imaging.
The incidence of spinal cord ischaemia during thoracic
endovascular repair is reported to range from 0 to 10% with
a figure of around 5% for larger series.10,11,17e21 In patients
with aneurysms, the Gore Tag pivotal trial reported an
incidence of 3% in a series of 139 patients and the clinical
trial for the TX2 device showed an overall incidence of
6%.5,6 Others have demonstrated an incidence of 4% in
a series of 326 with mixed pathology and in the EUROSTAR
Registry the incidence was 2.5% and was increased four-fold
with coverage of the left subclavian artery.7,18
In our series the rate of paraplegia was 5.5% and the
majority of patients presented in the perioperative period.
However in some the onset of symptoms was variable and
was delayed by up to six months. The level of sensory loss
and the distribution of motor weakness at presentation and
after treatment with inotropes and CSF drainage were
inconsistent. The magnitude of nerve injury appears
complex and could be related to the duration and severity
Vessels
revascularised
Procedure
duration
(min)
Additional
procedures
Territory and
aetiology
Symptom onset
(Post-op day)
Neurology Outcome
No 100 Proximal and distal
extension cuff
Anterior infarct Intra-op Permanent Dead
No 210 No Anterior infarct Intra-op Permanent Dead
No 140 Laparotomy for
ischaemic bowel
Anterior infarct 5 Permanent Dead
No 0 No Anterior infarct Intra-op Permanent Neuro-rehabilitation
Carotid to left
subclavian
bypass
60 No Posterior infarct 20 Partial Home
No 120 No Anterior infarct 2 Partial Home
No 55 No Anterior infarct Intra-op Permanent Neuro-rehabilitation
No 90 No Posterior infarct Intra-op Permanent Dead
Carotid to
carotid bypass
75 No Posterior infarct Intra-op Permanent Intermediate care
No 130 Further stent graft
for endoleak
Anterior infarct 6 Permanent Neuro-rehabilitation
No 80 No Posterior infarct Intra-op Permanent Intermediate care
No 160 No Anterior infarct Intra-op Permanent Dead
No 450 1. Femoralefemoral
bypass for
external iliac
artery avulsion
Anterior infarct Intra-op Permanent Dead
2. Proximal cuff day
two for endoleak
No 80 No Posterior infarct 2 Permanent Intermediate care
No 90 No Anterior infarct Intra-op Permanent Neuro-rehabilitation
No 105 No Anterior infarct 1 Permanent Neuro-rehabilitation
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reperfusion injury, perfusion pressure and the vascular
anatomy. Delayed presentation of paraplegia may be
related to very slight changes in local spinal cord haemo-
dynamics and late thrombosis of the spinal arteries. The
risk of thrombosis may be reduced by anticoagulation
but further evidence is required to support this conjecture.Table 5 Multivariate logistic regression analysis.
Stroke
Age
Atheromatous aneurysm
Renal impairment
Length of stent graft >200 mm
Left subclavian covered
Left subclavian covered and revascularised
Infra-renal aortic replacement or aneurysm
Paraplegia
Age
Atheromatous aneurysm
Renal impairment
Length of stent graft >200 mm
Left subclavian covered
Left subclavian covered and revascularised
Infra-renal aortic replacement or aneurysmCo-existing infra-renal pathology or a previous repair may
reduce a substantial proportion of the collateral network
supplying the spinal cord but this factor was not a signifi-
cant predictor of paraplegia in our series. The contribution
of the internal iliac artery to the distal spinal cord may be
important and angioplasty of ostial stenoses may perma-
nently reverse paraplegia.22 Longer endoluminal devicesOR 0.49 (0.15e1.65) P Z 0.25
OR 1.47 (0.46e4.70) P Z 0.52
OR 1.14 (0.37e3.52) P Z 0.82
OR 1.05 (0.99e1.11) P Z 0.08
OR 5.38 (1.42e20.40) P Z 0.01
OR 0.97 (0.10e9.78) P Z 0.98
OR 0.88 (0.28e2.80) P Z 0.83
OR 1.56 (0.45e5.48) P Z 0.49
OR 0.87 (0.26e2.90) P Z 0.82
OR 0.75 (0.24e2.36) P Z 0.62
OR 1.02 (0.97e1.09) P Z 0.44
OR 1.81 (0.54e6.07) P Z 0.34
OR 1.42 (0.26e7.81) P Z 0.69
OR 2.15 (0.71e6.50) P Z 0.18
Table 6 Demographics of patients with paraplegia.
Patient Sex Age Major
co-morbidities
Presentation Pathology Pre-operative
imaging
Previous
IRAAA repair
Infra-renal
disease
Anaesthetic
type
1 M 80 COPD Elective Aneurysm Angio; CT No No LA
2 F 76 AF Urgent Chronic dissection Angio; CT No Aneurysm Epidural,
conversion to GA
3 F 76 MI Elective Aneurysm Angio; CT; UA No No Epidural
4 M 69 Elective Aneurysm Angio; CT Yes No Epidural
5 M 74 Urgent Acute dissection Angio; CT No Dissection LA
6 M 58 Urgent Acute dissection CT No Dissection LA
7 M 79 MI Urgent Mycotic Not recorded No Aneurysm Epidural
8 M 61 MI; COPD Urgent Aneurysm Angio; CT No Aneurysm Epidural
9 M 69 Elective Aneurysm Not recorded No Aneurysm Epidural
10 M 74 MI; renal
impairment
Elective Chronic dissection Angio; CT No Dissection Epidural
11 F 74 MI Urgent Aorto-enteric fistula CT No No GA
12 F 84 Angina Elective Aneurysm Angio No Aneurysm Epidural
13 F 61 Elective Chronic dissection CT; UA No No Epidural
14 M 75 MI; COPD Elective Aneurysm Not recorded No Aneurysm Epidural
15 F 73 COPD Elective Aneurysm CT; UA No Aneurysm Epidural
16 F 79 Angina Elective Aneurysm CT; UA No No Epidural
308 R.E. Clough et al.occlude more intercostal arteries and have been shown to
associate with paraplegia in other studies but this was not
confirmed in our analysis.23,24 An important finding of the
current study was the early recognition of paraplegia by
using loco-regional anaesthesia which allowed early
recognition of neurological deficit and facilitated imme-
diate insertion of a CSF drain. The majority of patients with
paraplegia recovered their pre-operative neurological
function and returned home or to intermediate care.
New techniques are currently being developed to treat
ischaemic stroke. In addition tomechanical disruption of the
thrombus by catheter, guidewire and device manipulation,
chemical thrombectomy can be achieved with either intra-
venous (iv) or catheter-directed recombinant tissue plas-
minogen activator (tPA).25,26 In the PROACT II trial complete
flow in the middle cerebral artery was restored in 66% of
patients.27 New devices such as the Merci retriever, whichTable 7 Univariate logistic regression analysis.
Stroke
Age
Atheromatous aneurysm
Renal impairment
Length of stent graft >200 mm
Left subclavian covered
Left subclavian covered and revascularised
Infra-renal aortic replacement or aneurysm
Paraplegia
Age
Atheromatous aneurysm
Renal impairment
Length of stent graft >200 mm
Left subclavian covered
Left subclavian covered and revascularised
Infra-renal aortic replacement or aneurysmacts like a corkscrew to remove thrombus, and the Penumbra
aspiration catheter have shown recannulation rates of up to
80%.28,29 Magnetic resonance diffusion-weighted and CT
perfusion imaging are able to identify the ischaemic
penumbra, which is a salvageable area with reversible
ischaemia surrounding the cerebral infarct.30,31 Acute
neurological degeneration describes the increase in the size
of the cerebral infarction due to the viability of the
penumbra.32 The use of temporary extra-anatomic grafts
may avoid emboli and ensure haemodynamic stability during
aortic arch procedures.33 Devices which conform to the
aortic arch are now available and these may reduce the
incidence of embolisation during device insertion and
deployment. Future advances in imaging and endovascular
techniques will improve our understanding of the neurolog-
ical complications following thoracic aortic intervention and
guide individual patient risk stratification and treatment.OR 0.81 (0.29e2.20) P Z 0.67
OR 1.35 (0.49e3.73) P Z 0.57
OR 1.06 (0.37e3.08) P Z 0.91
OR 1.05 (1.00e1.11) P Z 0.03
OR 5.04 (1.7e14.9) P Z 0.004
OR 0.39 (0.05e3.05) P Z 0.37
OR 1.28 (0.43e3.79) P Z 0.66
OR 1.39 (0.49e3.92) P Z 0.54
OR 1.01 (0.38e2.83) P Z 0.94
OR 0.87 (0.28e2.67) P Z 0.81
OR 1.04 (0.99e1.10) P Z 0.09
OR 1.90 (0.57e6.30) P Z 0.30
OR 1.66 (0.60e4.60) P Z 0.33
OR 2.95 (1.07e8.13) P Z 0.04
Device Vessels
covered
Vessels
revascularised
Total length of
stent graft (cm)
Endoleak Additional
procedures
Neurology Outcome
TAG No No 30 No 1. Conduit left common
iliac artery
Partial
recovery
Dead
2. Right ileo-femoral bypass
for ischaemic leg
TAG LSCA No 45 Ib Aortic banding for endoleak Recovery Home
TAG LSCA No 50 Ib Distal cuff for endoleak Permanent Neuro-rehabilitation
TAG No No 55 No Colectomy for
ischaemic bowel
Permanent Intermediate care
TAG No No 10 No CSF drain blocked
and re-sited
Partial
recovery
Intermediate care
TAG No No 15 No No Recovery Home
Talent No No 25 Ia Proximal extension cuff Recovery Home
Talent LSCA No 45 No No Recovery Home
TAG Coeliac No 50 No Laparotomy for perforated
duodenal ulcer
Permanent Neuro-rehabilitation
Endofit No No 20 Ia Proximal extension cuff Recovery Home
TAG No No 55 Ia 1. Femoralefemoral
crossover for external
iliac artery avulsion
Permanent Neuro-rehabilitation
2. Proximal extension cuff
TX2 LSCA No 40 No No Partial recovery Intermediate care
Talent LCCA;
LSCA
Carotid to
carotid bypass
40 No Thoracotomy for
conversion to
Type A dissection
Partial
recovery
Home
Talent No No 40 No No Recovery Home
Talent LSCA;
coeliac
Left carotid to
subclavian bypass
35 No Internal iliac artery
angioplasty
Recovery Home
TX2 LSCA No 20 No No Permanent Neuro-rehabilitation
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Neurological complications of thoracic endoluminal repair
remain an important risk with an incidence of stroke and
paraplegia each affecting 5.5% of patients in this study.
Covering the origin of the left subclavian is associated with
a significantly increased risk of stroke. No patient or proce-
dural factor was identified as an independent predictor of
paraplegia. Cerebrospinal fluid drainage reduces the
severity of spinal cord ischaemia. Revascularisation of the
left subclavian artery may help to reduce the incidence of
stroke. New techniques to treat or prevent ischaemic stroke
may help to improve the outcome in these patients.Acknowledgements
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